Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ivarmacitinib sulfate by Jiangsu Hengrui Medicine for Systemic Lupus Erythematosus: Likelihood of Approval
Ivarmacitinib sulfate is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Systemic Lupus Erythematosus. According...
Ivarmacitinib sulfate by Jiangsu Hengrui Medicine for Graft Versus Host Disease (GVHD): Likelihood of Approval
Ivarmacitinib sulfate is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Graft Versus Host Disease...
Ivarmacitinib sulfate by Jiangsu Hengrui Medicine for Graft Versus Host Disease (GVHD): Likelihood of Approval
Ivarmacitinib sulfate is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Graft Versus Host Disease...